CompletedEarly Phase 1

Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers

United States26 participantsStarted 2008-10-10

Plain-language summary

RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice. PURPOSE: This randomized research study is evaluating a nurse practitioner hospice program for patients with terminal metastatic cancer and their families or caregivers.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Diagnosis of terminal metastatic cancer * Patient at Mayo Clinic in Jacksonville, Florida * Strong candidate for hospice care * Entering or planning to enter Community Hospice of Northeast Florida * Willing to undergo visits by an Advanced Registered Nurse Practitioner (ARNP) after hospice enrollment PATIENT CHARACTERISTICS: * Willing to participate in 2 palliative care consultations with an ARNP prior to hospice enrollment * Life expectancy \< 12 months * Able to complete questionnaires with or without assistance * Has a primary caregiver with an identified relationship to the patient PRIOR CONCURRENT THERAPY: * See Disease Characteristics

What they're measuring

Increased length of enrollment time in hospice care

Trial details

NCT IDNCT00896792

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-11-20

View on ClinicalTrials.gov More Hematopoietic/Lymphoid Cancer trials